Related Experiment Videos
Morquio B syndrome: a primary defect in beta-galactosidase
American Journal of Medical Genetics
|October 1, 1983
Summary
Morquio B syndrome involves beta-galactosidase with reduced activity and abnormal substrate affinity. This genetic disorder is allelic to GM1-gangliosidosis, impacting enzyme function and clinical presentation.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Morquio B syndrome is a rare genetic disorder.
- It affects lysosomal enzyme activity, specifically beta-galactosidase.
- Understanding the molecular basis is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the molecular and biochemical characteristics of beta-galactosidase in Morquio B syndrome.
- To compare these characteristics with those in GM1-gangliosidosis.
- To determine the allelic relationship between Morquio B syndrome and GM1-gangliosidosis.
Main Methods:
- Enzyme activity and substrate affinity assays in patient fibroblasts.
- Cell hybridization studies for complementation analysis.
- Analysis of urinary excretion of specific substrates.
Main Results:
- Fibroblasts in Morquio B syndrome show normal beta-galactosidase levels but reduced enzyme activity and altered substrate affinities.
- Beta-galactosidase from Morquio B patients exhibits significantly elevated Km for MU-beta-galactoside and undetectable affinity for keratan sulfate and urinary oligosaccharides.
- Cell hybridization confirms Morquio B syndrome and GM1-gangliosidosis belong to the same complementation group.
- Urinary keratan sulfate and oligosaccharide excretion is abnormal in Morquio B syndrome but normal in adult GM1-gangliosidosis.
Conclusions:
- Morquio B syndrome results from mutations in the beta-galactosidase structural gene, allelic to those in GM1-gangliosidosis.
- Distinct catalytic properties of beta-galactosidase explain the different clinical phenotypes between Morquio B syndrome and GM1-gangliosidosis.